Vol. 12 No. 1 (2005)

Published: 2005-10-01

Editorial

Editorial: De-risking novel therapeutic development â€“ time to stop blaming the molecule?

Simon Shohet
- PDF

Commentary

The European biotech sector: Could it achieve more?

Sam Fazeli
- PDF

Article

What to do when your technology is good but a licence is terminated

Manon Cox, Dan Adams
- PDF
Future employment in biotechnology in Germany

Klaus Menrad
- PDF
Human Tissue Act 2004: The age of consent arrives in the UK

Gillian Johnson, Alex Wilson
- PDF
Rethinking innovation in pharmaceutical R&D

Ann Baker, Jasween Gill
- PDF
Managing innovation in the pharmaceutical industry

Esther F Schmid, Dennis A Smith
- PDF
Taking stock in biotechnology futures

John L Jacobs
- PDF
Biotechnology in India: Emerging opportunities

Himanshu Parmar
- PDF
Marketspace: Leading therapeutic recombinant protein sales forecast and analysis to 2010

Mark J Belsey, Alex K Pavlou
- PDF

Legal and Regulatory Updates

Legal and regulatory update

John Wilkinson
- PDF